Grants and Contributions:
Title:
Steriwave ND photosensitizer naming
Agreement Number:
955188
Agreement Value:
$33,975.00
Agreement Date:
Jul 8, 2020 - Jan 31, 2021
Description:
US FDA requires the photosensitizer portion of the Steriwave ND treatment to have a proper and FDA-approved and registered drug name. Without this, Steriwave ND cannot be approved for sale in the U.S.
Organization:
National Research Council Canada
Expected Results:
CanExport SMEs is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Location:
Vancouver, British Columbia, CA V6E 4A6
Reference Number:
172-2020-2021-Q2-955188
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
892943895
Recipient Type:
For-profit organization
Recipient's Legal Name:
Ondine Biomedical Inc.
Federal Riding Name:
Vancouver Centre
Federal Riding Number:
59034
Program:
CanExport SMEs
Program Purpose:
CanExport SMEs is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Coverage:
CanExport SMEs projects lead to increased export diversification and growth for Canadian small and medium enterprises.
NAICS Code:
423450